Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: CRISPR Therapeutics AG, 3 years.
CRISPR Therapeutics AG
Director
Obsidian Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
CRISPR Therapeutics AG June 4, 202698.2%
-
CRISPR Therapeutics AG June 5, 202597.8%
-
CRISPR Therapeutics AG May 30, 202498.4%
-
CRISPR Therapeutics AG June 8, 202399.3%
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.